RxDoctor Payments Data

Elaine Burritt, NP

Adult Health · Hornell, NYNPI 1568506541

Payments from drug & device makers

$442in general payments, 2019–2025

Across 27 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$251
  • Pfizer$32
  • Exact Sciences$30
  • AbbVie$26
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$26
  • Phathom Pharmaceuticals, Inc.$22
  • plus $55 from 3 others

What the payments were for

  • Food & beverage$442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$442 in reported general payments places this provider in the 50th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York

Medicare billing

Part B allowed, 2024
$564
Medicare patients
18
Services billed
22

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin175$215,941
OzempicSemaglutide131$164,426
EliquisApixaban117$149,315
FarxigaDapagliflozin Propanediol101$113,738
TrulicityDulaglutide60$109,657
Trelegy ElliptaFluticasone/Umeclidin/Vilanter52$72,124
ProliaDenosumab26$43,060
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$33,050
XareltoRivaroxaban29$30,251
JanuviaSitagliptin Phosphate14$21,587
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$18,466
Nurtec OdtRimegepant Sulfate14$16,734
Tresiba Flextouch U-200Insulin Degludec11$16,330
EntrestoSacubitril/Valsartan14$13,705
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$11,320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Premarin, Dilantin$32$174,564154 claims
Novo NordiskOzempic$251$164,426131 claims
GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta$20$95,99088 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 3,828 adult health providers in New York.

Other adult health in Hornell

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →